Covalent Data Inc, which helps technology developers find licensing opportunities, announced it has completed a $1.2 million Series A-1 round, bringing its total funding to date to $4.8 million. The round was led by High Country Venture. Previously, the Denver-based company raised a $1 million seed round in July 2012 and $2.5 million in the first traunch of its Series A in November 2013 from High Country Venture and Techstars Ventures, according to CruchBase.
3 min read · 14 April 2016
TargEDys, which develops drugs and other medical products to regulate appetite, announced it has raised 5.8 million euros ($6.53 million) in a Series A round from Seventure Partners, NCI and Pontifax. The Rouen, France-based company will use the financing to launch human clinical studies for its products.
5 min read · 14 April 2016
Business development company Main Street Capital Corp (NYSE: MAIN) announced it will exit SambaSafety (aka Safety Holdings Inc) following a “majority recapitalization” of the Albuquerque-based company by ABRY Partners. Terms of the deal were not disclosed. “This transaction will result in the repayment of Main Street’s debt investment and the exit of Main Street’s equity investment in SambaSafety,” Main Street said in a statement. ABRY previously announced that it had acquired a majority of SambaSafety for an undisclosed amount on April 6.
2 min read · 14 April 2016
General Atlantic announced it has invested $61 million in Flipp Corporation to fuel growth at the company, which enables consumers to use their smart phones to access digital circulars from more than 800 retailers. GA joins Insight Venture Partners as a minority shareholder in the company. As part of the investment, GA Vice President Zachary Kaplan has joined Flipp’s board of directors. Formerly known as Wishabi, Flipp was founded in 2007 by former Microsoft engineers and previously raised $1 million in seed funding from an unnamed investor in January 2006, according to CrunchBase.
4 min read · 14 April 2016
Nylon Media, which is backed by Diversis Capital LLC and investor Marc Luzzato, has named Jamie Elden its president and chief revenue officer (CRO). Elden was previously CRO and head of entertainment at Federated Media, a subsidiary of Media General Company.
5 min read · 14 April 2016
Shape Technologies Group Inc, a portfolio company of American Industrial Partners, announced it has acquired Tops Co Ltd of South Korea. Terms of the deal were not disclosed. Both companies are suppliers of waterjet technology. AIP, which focuses on middle-market buyouts, acquired Shape in 2013, investing an undisclosed amount from its fifth fund, according to its website. Shape, based in Kent, Washington, has about 1,100 empoloyees in 18 sites around the world and produces annual revenue of $390 million, AIP’s website said. AIP closed on $1.8 billion for its sixth buyout fund last year, Buyouts reported.
3 min read · 13 April 2016
GREE, which operates a social network that users interact with through games on their phones, announced the launch of a $12 million fund to support virtual reality startups. Besdies GREE, limited partners in the fund include Colopl VR Fund and mixi. The fund, called GVR Fund, is managed by San Francisco-based GREE VR Capital LLC. It has already invested in two VR-related companies: VRChat Inc and SPACES Inc. GVR Fund is interested in gaming and non-gaming software and content companies.
3 min read · 13 April 2016
Audiovisual equipment seller Milestone AV Technologies announced it has acquired AV company Vaddio for an undisclosed amount. Milestone, based in Eden Praire, Minnesota, is majority owned by the Pritzker Group, Duchossois Capital Management and company management.
3 min read · 04 April 2016
Entasis Therapeutics, an AstraZeneca spinout developing products to treat drug-resistant bacterial infections, announced it has completed a $50 million Series B financing led by Clarus. Other investors included AstraZeneca, Frazier Healthcare Partners, Eventide Funds and Novo A/S. Entasis, based in Waltham, Massacusetts, raised a $40 million Series A from AstraZeneca in March 2015.
5 min read · 04 April 2016
Metabomed Ltd, an Israeli company developing drugs that target cancer metabolism, announced it has completed an extension of its Series A round from new and existing investors, bringing its total haul to $18 million. The new investors are Pfizer Inc and Arkin Holdings. They join existing investors MS Ventures, Boehringer Ingelheim Venture Fund, Pontifax Fund and the Technion Research and Development Foundation.
5 min read · 04 April 2016
